Literature DB >> 23710686

The Heidelberg retina tomograph ancillary study to the European glaucoma prevention study: study design and baseline factors.

Esther M Hoffmann1, Stefano Miglior, Thierry Zeyen, Valter Torri, Eliana Rulli, Shakhsanam Aliyeva, Irene Floriani, José Cunha-Vaz, Norbert Pfeiffer.   

Abstract

PURPOSE: To describe the study design and baseline factors of the Heidelberg Retina Tomograph ancillary study within the EGPS. Furthermore, to examine the relationship between HRT optic disc topographic measurements and baseline demographic and ocular factors.
METHODS: Four hundred and eighty-nine ocular hypertensive participants were included. Each participant completed HRT imaging at least annually. The associations between HRT measurements and IOP, central corneal thickness (CCT), baseline photographic estimates of vertical CDR ratio (CDR), asymmetry between the two eyes in CDR ratio and baseline visual field indices were assessed using regression analysis.
RESULTS: Associations between HRT measurements and vertical CDR by photographs were found for almost all stereometric optic disc parameters in both univariate and multivariate analysis. The strongest association was found between vertical CDR measurements and disc, cup and rim area; cup and rim volume, CDR area, linear CDR, mean and maximum cup depth and cup shape measure (all p < 0.0001). In multivariate analysis, pattern standard deviation (PSD) and HRT disc area had significant associations with several HRT optic disc measurements. Furthermore, CCT was significantly associated with reference height and the glaucoma probability score (GPS, outside normal limits).
CONCLUSIONS: The EGPS is the first multicentre, placebo-controlled randomized clinical trial to use HRT for monitoring optic disc changes in participants with ocular hypertension. We found strong associations between stereophotographic vertical CDR estimates, HRT disc area, PSD and several HRT parameters. We found, furthermore, that the parameters reference height and GPS were significantly related to central corneal thickness.
© 2013 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HRT parameter; central corneal thickness; glaucoma; intraocular pressure; ocular hypertension; pattern standard deviation; scanning laser ophthalmoscopy

Mesh:

Substances:

Year:  2013        PMID: 23710686     DOI: 10.1111/aos.12180

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  5 in total

1.  Advanced imaging for glaucoma study: design, baseline characteristics, and inter-site comparison.

Authors:  Phuc V Le; Xinbo Zhang; Brian A Francis; Rohit Varma; David S Greenfield; Joel S Schuman; Nils Loewen; David Huang
Journal:  Am J Ophthalmol       Date:  2014-11-08       Impact factor: 5.258

2.  Confocal scanning laser tomography of the optic nerve head on the patients with Alzheimer's disease compared to glaucoma and control.

Authors:  Sevda Aydin Kurna; Gokcen Akar; Ahmet Altun; Yasemin Agirman; Eren Gozke; Tomris Sengor
Journal:  Int Ophthalmol       Date:  2014-10-05       Impact factor: 2.031

3.  HRT for the Diagnosis and Detection of Glaucoma Progression.

Authors:  Jessica S Maslin; Kaweh Mansouri; Syril K Dorairaj
Journal:  Open Ophthalmol J       Date:  2015-05-15

4.  Comparison of Diagnostic Ability Between Wide-Field Swept-Source Optical Coherence Tomography Imaging Maps and Heidelberg Retina Tomograph 3 Optic Nerve Head Assessment to Discriminate Glaucomatous and Non-glaucomatous Eyes.

Authors:  Dimitrios Kourkoutas; George Triantafyllopoulos; Iordanis Georgiou; Aristotelis Karamaounas; Nikolaos Karamaounas; Konstadinos Sotiropulos; Dimitrios Kapralos
Journal:  Cureus       Date:  2022-08-19

5.  Morphometric Optic Nerve Head Analysis in Glaucoma Patients: A Comparison between the Simultaneous Nonmydriatic Stereoscopic Fundus Camera (Kowa Nonmyd WX3D) and the Heidelberg Scanning Laser Ophthalmoscope (HRT III).

Authors:  Siegfried Mariacher; Stephanie Hipp; Robert Wirthky; Gunnar Blumenstock; Karl-Ulrich Bartz-Schmidt; Focke Ziemssen; Ulrich Schiefer; Bogomil Voykov; Kai Januschowski
Journal:  J Ophthalmol       Date:  2016-05-30       Impact factor: 1.909

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.